HK85790A - Dichloroaniline derivatives - Google Patents

Dichloroaniline derivatives

Info

Publication number: HK85790A
Authority: HK; Hong Kong
Prior art keywords: dichloroaniline derivatives; dichloroaniline; derivatives
Prior art date: 1986-02-12

Application number

HK857/90A

Other languages

English (en)

Inventor

Lawrence Henry Charles Lunts

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-02-12

Filing date

1990-10-18

Publication date

1990-10-25

1990-10-18 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1990-10-25 Publication of HK85790A publication Critical patent/HK85790A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HK857/90A 1986-02-12 1990-10-18 Dichloroaniline derivatives HK85790A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868603475A GB8603475D0 (en)	1986-02-12	1986-02-12	Chemical compounds

Publications (1)

Publication Number	Publication Date
HK85790A true HK85790A (en)	1990-10-25

Family

ID=10592944

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK857/90A HK85790A (en)	1986-02-12	1990-10-18	Dichloroaniline derivatives

Country Status (37)

Country	Link
US (1)	US4937251A (sv)
JP (2)	JPS62258359A (sv)
KR (1)	KR870007886A (sv)
CN (1)	CN1020095C (sv)
AT (1)	AT394364B (sv)
AU (1)	AU596824B2 (sv)
BE (1)	BE1002129A3 (sv)
CA (1)	CA1301762C (sv)
CH (1)	CH670636A5 (sv)
CS (1)	CS402991A3 (sv)
CY (1)	CY1660A (sv)
DE (1)	DE3704223C2 (sv)
DK (1)	DK163991C (sv)
ES (1)	ES2004676A6 (sv)
FI (1)	FI83774C (sv)
FR (1)	FR2596049B1 (sv)
GB (2)	GB8603475D0 (sv)
GR (1)	GR870220B (sv)
HK (1)	HK85790A (sv)
HU (1)	HU199416B (sv)
IE (1)	IE59524B1 (sv)
IL (2)	IL81535A (sv)
IS (1)	IS1489B (sv)
IT (1)	IT1205978B (sv)
LU (1)	LU86768A1 (sv)
MX (1)	MX5220A (sv)
NL (1)	NL188408C (sv)
NO (1)	NO170629C (sv)
NZ (1)	NZ219241A (sv)
PH (1)	PH24067A (sv)
PL (1)	PL151050B1 (sv)
PT (1)	PT84273B (sv)
SE (1)	SE462562B (sv)
SG (1)	SG70590G (sv)
SU (1)	SU1590042A3 (sv)
ZA (1)	ZA87974B (sv)
ZW (1)	ZW2887A1 (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8703007D0 (en) *	1987-02-10	1987-03-18	Glaxo Group Ltd	Chemical compounds
US5149698A (en) *	1987-08-11	1992-09-22	Glaxo Group Limited	Chloroaniline derivatives
GB8718939D0 (en) *	1987-08-11	1987-09-16	Glaxo Group Ltd	Chemical compounds
ES2039646T3 (es) *	1987-11-13	1993-10-01	Glaxo Group Limited	Derivados de fenetanolamina.
KR920000717A (ko) *	1990-03-05	1992-01-29	원본미기재	디클로로아닐린 화합물
GB9104650D0 (en) *	1991-03-05	1991-04-17	Glaxo Group Ltd	Medicaments
US6419873B1 (en)	1999-03-19	2002-07-16	Q2100, Inc.	Plastic lens systems, compositions, and methods
US6436972B1 (en)	2000-04-10	2002-08-20	Dalhousie University	Pyridones and their use as modulators of serine hydrolase enzymes
TWI249515B (en)	2001-11-13	2006-02-21	Theravance Inc	Aryl aniline beta2 adrenergic receptor agonists
JP4575153B2 (ja) *	2002-06-18	2010-11-04	旭化成エレクトロニクス株式会社	電流測定方法および電流測定装置
US20070219223A1 (en) *	2006-03-07	2007-09-20	Endacea, Inc.	Compositions and methods for treating respiratory disorders
JP5626621B2 (ja)	2010-03-19	2014-11-19	株式会社日立産業制御ソリューションズ	フェイズドアレイ合成開口ソナーシステム
US9012450B2 (en)	2011-12-28	2015-04-21	Global Blood Therapeutics, Inc.	Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
HUE035069T2 (en)	2011-12-28	2018-05-02	Global Blood Therapeutics Inc	Substituted benzaldehyde compounds and their use to increase tissue oxygenation
US10266551B2 (en)	2013-03-15	2019-04-23	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
PE20160078A1 (es)	2013-03-15	2016-03-02	Global Blood Therapeutics Inc	Compuestos y sus usos para modular la hemoglobina
US20140274961A1 (en)	2013-03-15	2014-09-18	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en)	2013-03-15	2016-10-04	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en)	2013-03-15	2018-10-16	Global Blood Therapeutics, Inc.	Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9802900B2 (en)	2013-03-15	2017-10-31	Global Blood Therapeutics, Inc.	Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en)	2013-03-15	2015-02-10	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en)	2013-03-15	2017-03-28	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
CA2903022C (en)	2013-03-15	2021-11-09	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en)	2013-03-15	2016-08-23	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
CN105073728A (zh)	2013-03-15	2015-11-18	全球血液疗法股份有限公司	化合物及其用于调节血红蛋白的用途
EA201992707A1 (ru)	2013-11-18	2020-06-30	Глобал Блад Терапьютикс, Инк.	Соединения и их применения для модуляции гемоглобина
AP2016009261A0 (en)	2014-02-07	2016-06-30	Global Blood Therapeutics Inc	Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (fr)	2015-03-30	2018-02-06	Global Blood Therapeutics Inc	Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MX2018006832A (es)	2015-12-04	2018-11-09	Global Blood Therapeutics Inc	Regimenes de dosificacion de 2-hidroxi-6-((2-(1-isopropil-1h-piraz ol-5-il)-piridin-3-il)-metoxi)-benzaldehido.
TWI752307B (zh)	2016-05-12	2022-01-11	美商全球血液治療公司	新穎化合物及製造化合物之方法
TW202332423A (zh)	2016-10-12	2023-08-16	美商全球血液治療公司	包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
WO2020072377A1 (en)	2018-10-01	2020-04-09	Global Blood Therapeutics, Inc.	Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1618005A1 (de) *	1966-09-22	1971-09-09	Thomae Gmbh Dr K	Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
NL176168C (nl) *	1972-12-18	1985-03-01	Thomae Gmbh Dr K	Werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare nieuwe gesubstitueerde 1-(4-aminofenyl)-2-amino-ethanol-derivaten die, behalve een analgetische, uterusspasmolytische en anti-spastische werking op de dwarsgestreepte spieren, in het bijzonder een beta2-mimetische en/of beta1-blokkerende werking bezitten.
DE2711655A1 (de) *	1977-03-17	1978-09-21	Basf Ag	Pyridinyl-aminoalkylaether
CH635320A5 (en) *	1978-01-01	1983-03-31	Ciba Geigy Ag	1-(Azacyclic aralkoxyphenyl)-2- or -3-(bis-arylalkylamino)alkanes
ATE1899T1 (de) *	1979-06-16	1982-12-15	Beecham Group Plc	Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
NL8105170A (nl) *	1980-12-10	1982-07-01	Thomae Gmbh Dr K	Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
US4379166A (en) *	1981-08-03	1983-04-05	Schering Corporation	Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols
HU186654B (en) *	1982-12-28	1985-09-30	Richter Gedeon Vegyeszet	Process for producing new pyridine derivatives, acid additional salts and quaternary salts and pharmaceutical compositions containing them
DE3434271A1 (de) *	1984-09-19	1986-03-20	Beiersdorf Ag, 2000 Hamburg	Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8426191D0 (en) *	1984-10-17	1984-11-21	Glaxo Holdings Ltd	Chemical compounds
GB8525484D0 (en) *	1985-10-16	1985-11-20	Glaxo Group Ltd	Chemical compounds
GB8718939D0 (en) *	1987-08-11	1987-09-16	Glaxo Group Ltd	Chemical compounds

1986
- 1986-02-12 GB GB868603475A patent/GB8603475D0/en active Pending
1987
- 1987-02-10 IS IS3193A patent/IS1489B/is unknown
- 1987-02-10 GR GR870220A patent/GR870220B/el unknown
- 1987-02-11 BE BE8700109A patent/BE1002129A3/fr not_active IP Right Cessation
- 1987-02-11 CH CH527/87A patent/CH670636A5/fr not_active IP Right Cessation
- 1987-02-11 LU LU86768A patent/LU86768A1/fr unknown
- 1987-02-11 FI FI870554A patent/FI83774C/sv not_active IP Right Cessation
- 1987-02-11 NL NLAANVRAGE8700326,A patent/NL188408C/xx not_active IP Right Cessation
- 1987-02-11 SE SE8700535A patent/SE462562B/sv not_active IP Right Cessation
- 1987-02-11 US US07/013,895 patent/US4937251A/en not_active Expired - Fee Related
- 1987-02-11 PH PH34850A patent/PH24067A/en unknown
- 1987-02-11 ES ES8700341A patent/ES2004676A6/es not_active Expired
- 1987-02-11 ZA ZA87974A patent/ZA87974B/xx unknown
- 1987-02-11 NO NO870526A patent/NO170629C/no unknown
- 1987-02-11 NZ NZ219241A patent/NZ219241A/en unknown
- 1987-02-11 AT AT0028687A patent/AT394364B/de not_active IP Right Cessation
- 1987-02-11 AU AU68695/87A patent/AU596824B2/en not_active Ceased
- 1987-02-11 DE DE3704223A patent/DE3704223C2/de not_active Expired - Fee Related
- 1987-02-11 PL PL1987264054A patent/PL151050B1/pl unknown
- 1987-02-11 IT IT47630/87A patent/IT1205978B/it active
- 1987-02-11 IL IL81535A patent/IL81535A/xx not_active IP Right Cessation
- 1987-02-11 CN CN87101830A patent/CN1020095C/zh not_active Expired - Fee Related
- 1987-02-11 DK DK069887A patent/DK163991C/da active
- 1987-02-11 IE IE35087A patent/IE59524B1/en not_active IP Right Cessation
- 1987-02-11 GB GB8703059A patent/GB2187734B/en not_active Expired - Fee Related
- 1987-02-11 PT PT84273A patent/PT84273B/pt not_active IP Right Cessation
- 1987-02-11 FR FR878701698A patent/FR2596049B1/fr not_active Expired - Fee Related
- 1987-02-11 SU SU874202054A patent/SU1590042A3/ru active
- 1987-02-11 HU HU87530A patent/HU199416B/hu not_active IP Right Cessation
- 1987-02-11 ZW ZW28/87A patent/ZW2887A1/xx unknown
- 1987-02-12 MX MX522087A patent/MX5220A/es unknown
- 1987-02-12 KR KR870001162A patent/KR870007886A/ko not_active Application Discontinuation
- 1987-02-12 CA CA000529552A patent/CA1301762C/en not_active Expired - Fee Related
- 1987-02-12 JP JP62030644A patent/JPS62258359A/ja active Granted
1989
- 1989-02-07 IL IL89205A patent/IL89205A/xx not_active IP Right Cessation
1990
- 1990-05-21 JP JP2131124A patent/JPH0314565A/ja active Pending
- 1990-08-24 SG SG705/90A patent/SG70590G/en unknown
- 1990-10-18 HK HK857/90A patent/HK85790A/xx not_active IP Right Cessation
1991
- 1991-12-23 CS CS914029A patent/CS402991A3/cs unknown
1993
- 1993-05-14 CY CY1660A patent/CY1660A/xx unknown

Also Published As

Publication number	Publication date
CN87101830A (zh)	1987-09-09
FI870554A (fi)	1987-08-13
CA1301762C (en)	1992-05-26
ES2004676A6 (es)	1989-02-01
FR2596049A1 (fr)	1987-09-25
PL151050B1 (en)	1990-07-31
DK163991B (da)	1992-04-27
NO870526L (no)	1987-08-13
IE59524B1 (en)	1994-03-09
DK69887D0 (da)	1987-02-11
SE8700535D0 (sv)	1987-02-11
NO870526D0 (no)	1987-02-11
JPS62258359A (ja)	1987-11-10
CH670636A5 (sv)	1989-06-30
GB8603475D0 (en)	1986-03-19
IT8747630A0 (it)	1987-02-11
SG70590G (en)	1990-10-26
JPH0462311B2 (sv)	1992-10-05
IT1205978B (it)	1989-04-05
DK69887A (da)	1987-08-13
IS1489B (is)	1992-06-30
PH24067A (en)	1990-03-05
PT84273B (pt)	1989-09-14
US4937251A (en)	1990-06-26
MX5220A (es)	1993-11-01
CY1660A (en)	1993-05-14
LU86768A1 (fr)	1988-03-02
FR2596049B1 (fr)	1991-02-08
ZA87974B (en)	1987-12-30
IE870350L (en)	1987-08-12
HUT43566A (en)	1987-11-30
NO170629B (no)	1992-08-03
AT394364B (de)	1992-03-25
GB2187734B (en)	1990-05-30
IL81535A0 (en)	1987-09-16
BE1002129A3 (fr)	1990-07-24
IL89205A (en)	1993-04-04
ZW2887A1 (en)	1987-09-23
PL264054A1 (en)	1988-10-13
AU596824B2 (en)	1990-05-17
CN1020095C (zh)	1993-03-17
FI83774B (fi)	1991-05-15
GB8703059D0 (en)	1987-03-18
FI870554A0 (fi)	1987-02-11
NZ219241A (en)	1990-01-29
CS402991A3 (en)	1992-09-16
DK163991C (da)	1992-09-21
GR870220B (en)	1987-05-28
KR870007886A (ko)	1987-09-22
DE3704223A1 (de)	1987-08-20
NL188408C (nl)	1992-06-16
SE8700535L (sv)	1987-08-13
JPH0314565A (ja)	1991-01-23
PT84273A (en)	1987-03-01
IL81535A (en)	1990-11-05
NL188408B (nl)	1992-01-16
HU199416B (en)	1990-02-28
AU6869587A (en)	1987-08-13
IS3193A7 (is)	1987-08-13
NO170629C (no)	1992-11-11
ATA28687A (de)	1991-09-15
DE3704223C2 (de)	1995-05-24
NL8700326A (nl)	1987-09-01
SE462562B (sv)	1990-07-16
SU1590042A3 (ru)	1990-08-30
FI83774C (sv)	1991-08-26
GB2187734A (en)	1987-09-16

Legal Events

Date	Code	Title	Description
2004-12-15	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Publication	Publication Date	Title
GB2187734B (en)	1990-05-30	Dichloroaniline derivatives
GB2190676B (en)	1990-05-30	Imidazoquinolinylether derivatives
EP0253500A3 (en)	1989-01-04	Acylanilide derivatives
GB8719310D0 (en)	1987-09-23	Piperidylaminotriazine derivatives
GB2198132B (en)	1990-07-25	1-piperazinylpyrimidine derivatives
GB8629875D0 (en)	1987-01-28	Pyridazodiazepine derivatives
GB2185483B (en)	1990-10-24	Pyroglutamide derivatives
EP0247381A3 (en)	1988-11-23	5-flurorouracil derivatives
GB2182658B (en)	1990-01-31	Dichloroaniline derivatives
EP0269839B1 (en)	1990-09-12	5-acylamino-pyrazole derivatives
GB2198729B (en)	1990-05-02	Azaspirodecane derivatives
AR245109A1 (es)	1993-12-30	Un procedimiento para la preparacion de 5-fenil-5h-indeno/1,2-d/ pirimidina.
EP0246002A3 (en)	1988-10-05	Alkenamide derivatives
GB2189487B (en)	1990-05-23	Ergolene derivatives
GB2186575B (en)	1989-11-08	Abietamide derivatives
EP0267024A3 (en)	1989-03-15	Hydrofluorene derivatives
GR870728B (en)	1987-09-21	Tetrahydronaphalin derivatives
GR860938B (en)	1986-08-07	Dichloroaniline derivatives
GB8705006D0 (en)	1987-04-08	5-acyloxy-13beta-alkyl-milbemycin derivatives
EP0244193A3 (en)	1989-01-18	Dihalogen-substituted thiocyanopyrimidine derivatives
IE860547L (en)	1986-09-01	Labdan derivatives
GB8628524D0 (en)	1987-01-07	Benzothiopyranone derivatives
GB8701837D0 (en)	1987-03-04	Abietamide derivatives
HK63093A (en)	1993-07-09	Hydroxylindol derivatives
GB8622071D0 (en)	1986-10-22	Hydroxtheteroaryl derivatives